Drug intelligence / Profile preview

Fimosin Gel

Development stage
Unknown
Lead developer
Epitech
Modality
Small Molecules
Administration
Topical
01

Overview

Fimosin Gel is a topical pediatric medical device developed by Epitech Group SpA for the symptomatic treatment of inflammatory conditions of the male genital area. Its primary active ingredient is **adelmidrol**, a synthetic ALIAmide (Autacoid Local Injury Antagonism amide) and N-acylethanolamine derivative. Adelmidrol acts by modulating the activation of local mast cells and non-neuronal immune cells, thereby exerting anti-inflammatory and soothing effects. The gel is specifically indicated for the relief of redness, edema, erythema, burning, and itching associated with balanitis and balanoposthitis. It is also used for the resolution of physiological phimosis in pediatric patients and as a post-surgical treatment for pathological phimosis. The formulation includes additional components such as hyaluronic acid, phytosphingosine, and biotin to support hydration and the restoration of the mucocutaneous barrier.

Brand names
Fimosin GelFIMOSIN® GEL
Other names
Fimosin
02

Targets

PPARA (Peroxisome proliferator-activated receptor alpha)

Beyond the preview

Go deeper on Fimosin Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fimosin Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call